Discover how biomarker strategies are transforming oncology trials and accelerating precision medicine breakthroughs.

Can Trump’s deal with the UK become a model for similar drug price agreements?

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;